• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子动力学模拟的 AT1R 中 TRV027 偏激动剂的决定因素。

Biased Agonist TRV027 Determinants in AT1R by Molecular Dynamics Simulations.

机构信息

Department of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences , University of São Paulo , Av. Prof. Lineu Prestes 580 , 05508-900 São Paulo - SP , Brazil.

Laboratory of Genetics and Molecular Cardiology, Heart Institute , University of São Paulo Medical School , Av. Dr. Enéas de Carvalho Aguiar 44 , 05403-900 São Paulo - SP , Brazil.

出版信息

J Chem Inf Model. 2019 Feb 25;59(2):797-808. doi: 10.1021/acs.jcim.8b00628. Epub 2019 Feb 4.

DOI:10.1021/acs.jcim.8b00628
PMID:30668103
Abstract

Functional selectivity is a phenomenon observed in G protein-coupled receptors in which intermediate active-state conformations are stabilized by mutations or ligand binding, resulting in different sets of signaling pathways. Peptides capable of selectively activating β-arrestin, known as biased agonists, have already been characterized in vivo and could correspond to a new therapeutic approach for treatment of cardiovascular diseases. Despite the potential of biased agonism, the mechanism involved in selective signaling remains unclear. In this work, molecular dynamics simulations were employed to compare the conformational profile of the angiotensin II type 1 receptor (AT1R) crystal bound to angiotensin II, bound to the biased ligand TRV027, and in the apo form. Our results show that both ligands induce changes near the NPxxY motif in transmembrane domain 7 that are related to receptor activation. However, the biased ligand does not cause the rotamer toggle alternative positioning and displays an exclusive hydrogen-bonding pattern. Our work sheds light on the biased agonism mechanism and will help in the future design of novel biased agonists for AT1R.

摘要

功能选择性是 G 蛋白偶联受体中观察到的一种现象,其中中间活性构象通过突变或配体结合稳定,导致不同的信号通路。已经在体内表征了能够选择性激活β-arrestin 的肽,称为偏向激动剂,它们可能对应于心血管疾病治疗的新治疗方法。尽管偏向激动剂具有潜力,但选择性信号传递所涉及的机制仍不清楚。在这项工作中,我们使用分子动力学模拟来比较与血管紧张素 II 结合的血管紧张素 II 型 1 受体 (AT1R) 晶体、与偏向配体 TRV027 结合的 AT1R 晶体和apo 形式的 AT1R 晶体的构象特征。我们的结果表明,两种配体都在跨膜域 7 中的 NPxxY 基序附近诱导变化,这与受体激活有关。然而,偏向配体不会引起变构体切换替代定位,并且显示出独特的氢键模式。我们的工作阐明了偏向激动剂的作用机制,并将有助于未来设计用于 AT1R 的新型偏向激动剂。

相似文献

1
Biased Agonist TRV027 Determinants in AT1R by Molecular Dynamics Simulations.基于分子动力学模拟的 AT1R 中 TRV027 偏激动剂的决定因素。
J Chem Inf Model. 2019 Feb 25;59(2):797-808. doi: 10.1021/acs.jcim.8b00628. Epub 2019 Feb 4.
2
Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.膜拉伸对β-抑制蛋白偏向性血管紧张素II 1型受体信号传导的变构调节。
J Biol Chem. 2014 Oct 10;289(41):28271-83. doi: 10.1074/jbc.M114.585067. Epub 2014 Aug 28.
3
Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells.单细胞力谱技术研究血管紧张素 II 型 1 受体与活细胞中不同偏向配体的相互作用。
Anal Bioanal Chem. 2018 May;410(14):3275-3284. doi: 10.1007/s00216-018-0956-3. Epub 2018 Feb 28.
4
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.血管紧张素 II 型 1 型受体研究的当前热点:关注反向激动剂、受体二聚化和偏向激动作用。
Pharmacol Res. 2017 Sep;123:40-50. doi: 10.1016/j.phrs.2017.06.013. Epub 2017 Jun 23.
5
Biased Agonism of the Angiotensin II Type I Receptor.血管紧张素II 1型受体的偏向性激动作用
Int Heart J. 2015;56(5):485-8. doi: 10.1536/ihj.15-256. Epub 2015 Jul 14.
6
Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor.偏倚激动剂在血管紧张素 II 型 1 受体中差异调节受体构象集合。
J Mol Graph Model. 2023 Jan;118:108365. doi: 10.1016/j.jmgm.2022.108365. Epub 2022 Oct 20.
7
Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.利用分子动力学模拟鉴定与Gq/11蛋白途径和β-抑制蛋白途径相关的血管紧张素II 1型受体的不同构象
J Biol Chem. 2015 Jun 19;290(25):15835-15854. doi: 10.1074/jbc.M114.627356. Epub 2015 May 1.
8
Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.利用加速分子动力学模拟β(2)肾上腺素能受体的偏向激动剂。
Biochemistry. 2013 Aug 20;52(33):5593-603. doi: 10.1021/bi400499n. Epub 2013 Aug 7.
9
β-Arrestin-Biased Agonist Targeting the Brain ATR (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension.β-arrestin 偏向激动剂靶向脑 ATR(血管紧张素 II 型 1 型受体)可增加去氧皮质酮醋酸盐盐高血压对盐水的厌恶感并降低血压。
Hypertension. 2021 Feb;77(2):420-431. doi: 10.1161/HYPERTENSIONAHA.120.15793. Epub 2020 Nov 30.
10
Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.构象生物传感器揭示了异二聚体血管紧张素AT1与前列腺素F2α受体之间的变构相互作用。
J Biol Chem. 2017 Jul 21;292(29):12139-12152. doi: 10.1074/jbc.M117.793877. Epub 2017 Jun 5.

引用本文的文献

1
Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist.通过将奥美沙坦结构修饰为偏向激动剂来开发一种非肽类血管紧张素II 1型受体配体。
Biomedicines. 2023 May 19;11(5):1486. doi: 10.3390/biomedicines11051486.
2
Comparative evaluation of biased agonists Sarcosine , d-Alanine -Angiotensin (Ang) II (SD Ang II) and Sarcosine , Isoleucine -Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT receptors.沙丙氨酸、d-丙氨酸-血管紧张素(Ang)II(SD Ang II)和沙丙氨酸、异亮氨酸-血管紧张素 II(SI Ang II)及其放射性碘标记同系物与大鼠肝细胞膜 AT 受体的结合比较评价。
Pharmacol Res Perspect. 2023 Feb;11(1):e01053. doi: 10.1002/prp2.1053.
3
Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes.
靶向脑血管疾病的血管紧张素 II 型 1 型受体:偏向信号带来新希望。
Int J Mol Sci. 2021 Jun 23;22(13):6738. doi: 10.3390/ijms22136738.
4
In silico prediction of ARB resistance: A first step in creating personalized ARB therapy.在体预测 ARB 耐药性:制定个体化 ARB 治疗方案的第一步。
PLoS Comput Biol. 2020 Nov 25;16(11):e1007719. doi: 10.1371/journal.pcbi.1007719. eCollection 2020 Nov.
5
The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor.β-抑制蛋白在信号组织及血管紧张素Ⅱ1型受体(AT1)调节中的作用
Front Endocrinol (Lausanne). 2019 Aug 6;10:519. doi: 10.3389/fendo.2019.00519. eCollection 2019.